Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Neurobiological Technologies, Inc.
No Price
Closing Price OTC 28.04.2026:
0,0001 USD
28.04.2026 20:00
Current Prices from Neurobiological Technologies, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
NTII
USD
28.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Neurobiological Technologies, Inc. Share
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.
Company Data
NameNeurobiological Technologies, Inc.
CompanyNeurobiological Technologies, Inc.
Primary Exchange
UTC
ISINUS64124W3043
Asset ClassShare
SectorHealthcare
IndustryBiotechnology
CEOJohn B. Stuppin
CountryUnited States of America
CurrencyUSD
Employees0,0 T
Address2000 Powell Street, 94608 EmeryVille
IPO Date1994-10-31
Dividends from 'Neurobiological Technologies, Inc.'
Ex-Date
Dividend per Share
18.12.2012
0,06 USD
10.12.2009
0,18 USD
19.11.2009
0,75 USD
Stock Splits
Date
Split
17.09.2007
1:7
Ticker Symbols
Name
Symbol
Over The Counter
NTII
More Shares
Investors who hold Neurobiological Technologies, Inc. also have the following shares in their portfolio:
